Insider Transactions Reported by 21 Insiders of Moderna, Inc.

Symbol
MRNA on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Moderna, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Stephane Bancel Chief Executive Officer, Director $511,509,633 01 Mar 2026
Ph.D. Noubar B. Afeyan Director $183,139,027 -$703,306 -0.38% 11 Dec 2025
Stephen Hoge President $87,303,959 -$7,814,840 -8.2% 27 Feb 2026
Paul Sagan Director $15,693,665 30 Apr 2025
Shannon Thyme Klinger Chief Legal Officer $2,674,429 -$726,047 -21% 05 Mar 2026
James M. Mock Chief Financial Officer $2,585,182 05 Mar 2026
Stephen Berenson Director $2,517,789 03 May 2024
Arpa Garay Chief Commercial Officer $1,524,005 05 Dec 2023
Juan Andres Chief Technical Operations and Quality Officer $1,330,232 28 Dec 2022
David W. Meline Chief Financial Officer $645,077 09 Aug 2022
Paul Burton Chief Medical Officer $541,865 04 Nov 2022
Elizabeth G. Nabel Director $193,267 30 Apr 2025
Sandra Horning Director $173,744 30 Apr 2025
David M. Rubenstein Director $133,707 05 Aug 2025
Abbas Hussain Director $107,441 -$22,646 -17% 09 Dec 2025
Lori M. Henderson General Counsel and Secretary $93,614 27 May 2021
Elizabeth E. Tallett Director 30 Apr 2025
Robert Langer Director 06 May 2024
Jorge M. Gomez Officer 09 May 2022
Tal Zvi Zaks Chief Medical Officer 30 Jun 2021
Francois Nader Director 30 Apr 2025

Recent Insider Transactions by Companies or Individuals for Moderna, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Shannon Thyme Klinger MRNA Common Stock Tax liability -7.98% -5,704 65,782 05 Mar 2026 Direct
Shannon Thyme Klinger MRNA Common Stock Options Exercise 19.8% 11,797 71,486 05 Mar 2026 Direct
Shannon Thyme Klinger MRNA Restricted Stock Units Options Exercise -8.33% -11,797 129,774 05 Mar 2026 Direct
James M. Mock MRNA Common Stock Tax liability -9.1% -5,704 56,998 05 Mar 2026 Direct
James M. Mock MRNA Common Stock Options Exercise 23.2% 11,797 62,702 05 Mar 2026 Direct
James M. Mock MRNA Restricted Stock Units Options Exercise -8.33% -11,797 129,774 05 Mar 2026 Direct
Shannon Thyme Klinger MRNA Common Stock Sale -18.9% $726,047 $52.29 -13,885 59,689 02 Mar 2026 Direct
Shannon Thyme Klinger MRNA Common Stock Options Exercise 23.3% 13,885 73,574 02 Mar 2026 Direct
Shannon Thyme Klinger MRNA Stock Option (Right to Buy) Options Exercise -25% -13,885 41,658 02 Mar 2026 Direct
Stephane Bancel MRNA Stock Option (Right to Buy) Award 250,932 250,932 01 Mar 2026 Direct
Stephen Hoge MRNA Restricted Stock Units Award 165,230 165,230 01 Mar 2026 Direct
Stephen Hoge MRNA Stock Option (Right to Buy) Award 125,466 125,466 01 Mar 2026 Direct
Shannon Thyme Klinger MRNA Restricted Stock Units Award 38,553 38,553 01 Mar 2026 Direct
Shannon Thyme Klinger MRNA Stock Option (Right to Buy) Award 29,275 29,275 01 Mar 2026 Direct
James M. Mock MRNA Restricted Stock Units Award 49,569 49,569 01 Mar 2026 Direct
James M. Mock MRNA Stock Option (Right to Buy) Award 37,639 37,639 01 Mar 2026 Direct
Stephen Hoge MRNA Common Stock Tax liability -1.3% -19,260 1,457,763 27 Feb 2026 Direct
Stephen Hoge MRNA Common Stock Options Exercise 2.74% 39,830 1,495,950 27 Feb 2026 Direct
Stephen Hoge MRNA Restricted Stock Units Options Exercise -100% -39,830 0 27 Feb 2026 Direct
Shannon Thyme Klinger MRNA Common Stock Tax liability -8.13% -4,837 54,647 27 Feb 2026 Direct
Shannon Thyme Klinger MRNA Common Stock Options Exercise 18.6% 9,999 63,878 27 Feb 2026 Direct
Shannon Thyme Klinger MRNA Restricted Stock Units Options Exercise -100% -9,999 0 27 Feb 2026 Direct
James M. Mock MRNA Common Stock Tax liability -10.5% -5,323 45,393 27 Feb 2026 Direct
James M. Mock MRNA Common Stock Options Exercise 24.6% 11,004 55,693 27 Feb 2026 Direct
James M. Mock MRNA Restricted Stock Units Options Exercise -89.3% -11,004 1,315 27 Feb 2026 Direct
Stephen Hoge MRNA Common Stock Sale -9.89% $7,814,840 $48.84 -160,009 1,457,427 23 Feb 2026 Direct
Stephen Hoge MRNA Common Stock Options Exercise 11% 160,009 1,617,436 23 Feb 2026 Direct
Stephen Hoge MRNA Stock Option (Right to Buy) Options Exercise -76.8% -160,009 48,330 23 Feb 2026 Direct
James M. Mock MRNA Common Stock Tax liability -2.75% -1,278 45,224 11 Feb 2026 Direct
James M. Mock MRNA Common Stock Award 5.99% 2,630 46,502 11 Feb 2026 Direct
Shannon Thyme Klinger MRNA Common Stock Tax liability -2.39% -1,334 54,527 11 Feb 2026 Direct
Shannon Thyme Klinger MRNA Common Stock Award 4.94% 2,630 55,861 11 Feb 2026 Direct
Stephen Hoge MRNA Common Stock Tax liability -0.16% -2,362 1,457,427 11 Feb 2026 Direct
Stephen Hoge MRNA Common Stock Award 0.34% 4,884 1,459,789 11 Feb 2026 Direct
Stephane Bancel MRNA Common Stock Tax liability -0.09% -5,450 6,187,791 11 Feb 2026 Direct
Stephane Bancel MRNA Common Stock Award 0.18% 11,271 6,193,241 11 Feb 2026 Direct
James M. Mock MRNA Common Stock Tax liability -1.75% -780 43,872 05 Jan 2026 Direct
James M. Mock MRNA Common Stock Options Exercise 3.36% 1,452 44,652 05 Jan 2026 Direct
James M. Mock MRNA Restricted Stock Units Options Exercise -25% -1,452 4,359 05 Jan 2026 Direct
Ph.D. Noubar B. Afeyan MRNA Common Stock Sale -85.9% $703,306 $29.48 -23,853 3,924 11 Dec 2025 By Flagship Pioneering, Inc.
Ph.D. Noubar B. Afeyan MRNA Common Stock Options Exercise 607.9% 23,853 27,777 11 Dec 2025 By Flagship Pioneering, Inc.
Ph.D. Noubar B. Afeyan MRNA Stock Option (Right to Buy) Options Exercise -100% -23,853 0 11 Dec 2025 By Flagship Pioneering, Inc.
Stephane Bancel MRNA Common Stock Options Exercise 12.5% 688,073 6,181,970 11 Dec 2025 Direct
Stephane Bancel MRNA Stock Option (Right to Buy) Options Exercise -100% -688,073 0 11 Dec 2025 Direct
Abbas Hussain MRNA Common Stock Sale -25% $13,910 $27.60 -504 1,515 09 Dec 2025 Direct
James M. Mock MRNA Common Stock Tax liability -34.6% -22,817 43,200 05 Dec 2025 Direct
James M. Mock MRNA Common Stock Options Exercise 250.6% 47,190 66,017 05 Dec 2025 Direct
James M. Mock MRNA Restricted Stock Units Options Exercise -25% -47,190 141,571 05 Dec 2025 Direct
Shannon Thyme Klinger MRNA Common Stock Tax liability -30% -22,817 53,231 05 Dec 2025 Direct
Shannon Thyme Klinger MRNA Common Stock Options Exercise 163.5% 47,190 76,048 05 Dec 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.